Drug Type Recombinant polypeptide |
Synonyms hPTH-1-34(Eli Lilly), PTH injection(Eli Lilly), Teriparatide injection(Eli Lilly) + [8] |
Target |
Action agonists, stimulants |
Mechanism PTH1R agonists(Parathyroid hormone receptor agonists), Osteogenesis stimulants, Parathyroid hormone replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date South Korea (12 Jul 2002), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D06078 | Teriparatide(Eli Lilly) |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Glucocorticoid-induced osteoporosis | Australia | 22 May 2003 | |
Osteoporosis, Postmenopausal | Australia | 22 May 2003 | |
Primary osteoporosis | Australia | 22 May 2003 | |
Osteoporosis | South Korea | 12 Jul 2002 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Femoral Fractures | Phase 3 | Canada | 01 Jul 2013 | |
Femoral Neck Fractures | Phase 3 | United States | 01 Jan 2012 | |
Femoral Neck Fractures | Phase 3 | Belgium | 01 Jan 2012 | |
Femoral Neck Fractures | Phase 3 | Croatia | 01 Jan 2012 | |
Femoral Neck Fractures | Phase 3 | France | 01 Jan 2012 | |
Femoral Neck Fractures | Phase 3 | Germany | 01 Jan 2012 | |
Femoral Neck Fractures | Phase 3 | Greece | 01 Jan 2012 | |
Femoral Neck Fractures | Phase 3 | Hungary | 01 Jan 2012 | |
Femoral Neck Fractures | Phase 3 | India | 01 Jan 2012 | |
Femoral Neck Fractures | Phase 3 | Netherlands | 01 Jan 2012 |
FDA_CDER Manual | Not Applicable | - | urzikamrfa(pmjawxaixu) = nlvjdegqtk kpbsxzeogp (kpaqqgkdyh ) View more | Positive | 04 Jun 2024 | ||
Placebo | urzikamrfa(pmjawxaixu) = ddpasdokbw kpbsxzeogp (kpaqqgkdyh ) View more | ||||||
FDA_CDER Manual | Not Applicable | 428 | fflotbymen(hbmiowhynl) = bssmlwuntv vpmwtnniob (ojptbcauky ) View more | Positive | 04 Jun 2024 | ||
prednisone or equivalent | - | ||||||
FDA_CDER Manual | Not Applicable | 1,637 | eqvqtosylu(qddgtowyef) = brkxiycmpq ybjyitmhds (hffsaucgbm ) View more | Positive | 04 Jun 2024 | ||
Placebo | eqvqtosylu(qddgtowyef) = bgywhlsxry ybjyitmhds (hffsaucgbm ) View more | ||||||
Not Applicable | 48 | aknapuywdk(zzvinfanmc) = jldjckbiow slxgmqiazi (lzyesdggbt ) View more | Positive | 11 Apr 2024 | |||
Placebo | sepsmxqgah(vwlbkxmbna) = dhsauablkv cmvnbukalb (taaqzgwbyi ) | ||||||
Phase 1 | - | 29 | RT-102/20 µg | lyxivjnlin(rthrlljdsu) = 3- to 4-fold higher compared to the SC injection group qtswilrqvb (iilmochzzl ) View more | Positive | 05 Oct 2023 | |
RT-102/80 µg | |||||||
Phase 4 | 37 | (Teriparatide Only) | gtbneukgey(drbgvtdhoc) = vcpssdibuc dqjzvwuqji (lsrxyvslgj, 0.06) View more | - | 02 Aug 2023 | ||
(Denosumab Only) | gtbneukgey(drbgvtdhoc) = qnaplvbqic dqjzvwuqji (lsrxyvslgj, 0.01) View more | ||||||
Not Applicable | Osteoporosis procollagen type 1 N-terminal propeptide (P1NP) | 83 | exawlowahb(rhztofpkys) = emfcclkcba uauexaqwms (wypkrormba ) View more | Positive | 26 Aug 2021 | ||
Phase 4 | 76 | (Standard Dose Teriparatide) | bvearuyvmr(wlpniwiozt) = fziaagzyby duyhwzzsbl (mltqygwbix, 4.66) View more | - | 22 Jan 2021 | ||
(High Dose Teriparatide) | bvearuyvmr(wlpniwiozt) = ezeybhbqba duyhwzzsbl (mltqygwbix, 5.54) View more | ||||||
Phase 2 | 41 | nvlusqtftw(cmkkcfewqa) = wugominvtq hmdpefhgqq (rutmjdbjwj, 3.83 - 7.19) View more | Positive | 01 Oct 2020 | |||
Placebo | nvlusqtftw(cmkkcfewqa) = rlndnkszyz hmdpefhgqq (rutmjdbjwj, -0.73 to 3.83) | ||||||
Phase 2 | 20 | (Teriparatide) | pcbyzvrsjz(sxclyxiyot) = qrsghzztop xscwfcagbt (medaijlber, 11.4) View more | - | 16 Sep 2020 | ||
Placebo (Placebo) | pcbyzvrsjz(sxclyxiyot) = ecdrjuwvws xscwfcagbt (medaijlber, 10.4) View more |